Valneva SE announced the earnings guidance for 2024. For the year Product sales expected between ?150 million and ?180 million, reflecting continued revenue growth for proprietary products and IXCHIQ®?s launch-year sales, despite anticipated supply constraints for third-party products and IXIARO®.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.256 EUR | +0.06% | -3.67% | -31.02% |
07/05 | Valneva SE Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/05 | Transcript : Valneva SE, Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.02% | 485M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva Se Announces Earnings Guidance for 2024